MET MetLife Inc.

Maya Kiyokawa Joins MetLife Investment Management as Director in the Institutional Client Group in Tokyo

MetLife, Inc. (NYSE: MET) today announced that it has hired Maya Kiyokawa as a director in the Institutional Client Group of MetLife Investment Management (MIM). Kiyokawa will lead new business development in Japan and will be based in Tokyo.

Prior to joining MetLife, Kiyokawa served as director of the alternative product sales department in Japan for Teneo Partners. Prior to that, she served as a senior consultant at Osborne Incorporated. She has also held senior roles at Deutsche Asset Management (Japan) Limited and Fidelity Investments Japan Limited in senior client services roles.

“Maya is an excellent addition to the team at MetLife Investment Management in Asia,” said Joseph Pollaro, chief operating officer of MIM. “Her international relationship management background, which includes more than16 years of direct experience and more than 25 years of valuable professional experience, will be an asset to MetLife as we grow MIM’s institutional asset management business in Asia, a vital and growing market for us.”

The addition of Kiyokawa to the MIM team in Japan reflects both the business’ commitment to the region and the importance of the market to MetLife’s investment management business. As part of her role, Kiyokawa will build partnerships with retirement funds, insurance companies, government funds and trust banks to raise MetLife’s profile and visibility in Japan. Her experience will be leveraged to build relationships in private debt and equity markets for real estate, infrastructure and corporate private placement bonds.

Kiyokawa holds a bachelor’s degree in commerce and business administration and accounting from the University of Alabama.

MetLife Investment Management (“MIM”) is MetLife’s institutional investment management business. MIM is responsible for investments in a range of asset sectors, including corporate and infrastructure private placement debt, real estate equity, commercial mortgage loans, customized index strategies, structured finance, emerging market debt and high yield debt.

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates ("MetLife"), is one of the largest life insurance companies in the world. Founded in 1868, MetLife is a global provider of life insurance, annuities, employee benefits and asset management. Serving approximately 100 million customers, MetLife has operations in nearly 50 countries and holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

L0117489261[exp1217]

EN
06/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MetLife Inc.

Moody's Ratings rates MetLife’s subordinated debentures Baa1 (hyb)

Please see for any updates on changes to the lead rating analyst and to the Moody's legal entity that has issued the rating. Please see the issuer/deal page on for additional regulatory disclosures for each credit rating. The rating of the deben...

Moody's Ratings rates MetLife’s subordinated debentures Baa1 (hyb)

New York , February 24, 2026 – Moody's Ratings (Moody's) has assigned a Baa1 (hyb) rating to the subordinated debentures issued by MetLife, Inc. (MetLife, NYSE: MET, senior debt A3). The debentures are being issued off MetLife's multi-purpose shelf registration statement filed in May 2025 and the pr...

Moody’s Ratings assigns ratings to MetLife’s shelf (senior unsecured a...

Moody’ s Ratings assigns ratings to MetLife’ s shelf. New York, January 5, 2026– Moody’ s Ratings has assigned provisional ratings to. MetLife, Inc.’ s shelf registration filed on May 16, 2025.

Metlife Inc: 1 director

A director at Metlife Inc sold/gave away 30,684 shares at 0.000USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch